Article Information
History
- April 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Issaka Sagara, MD1,*,
- John Woodford, MBBS2,*,
- Mamady Kone, MD1,
- Mahamadoun Hamady Assadou, MD1,
- Abdoulaye Katile, MD1,
- Oumar Attaher, PharmD,MS1,
- Amatigue Zeguime, PharmD1,
- M’Bouye Doucoure1, BSc,
- Emily Higbee, MSPH2,
- Jacquelyn Lane, PA2,
- Justin Doritchamou, PhD,
- Irfan Zaidi, PhD,
- Dominic Esposito, PhD3,
- Jennifer Kwan, PhD4,
- Kaitlyn Sadtler, PhD5,
- Alassane Dicko, MD1 and
- Patrick Duffy, MD2,*
- 1Malaria Research and Teaching Center, University of Sciences, Techniques, and Technology of Bamako, Mali
- 2Laboratory of Malaria Immunology and Vaccinology, National Institutes of Health, USA
- 3Frederic National Laboratory for Cancer Research, National Insitutes of Health, National Institutes of Health, USA
- 4Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, USA
- 5National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA
- ↵#Corresponding author; email: patrick.duffy{at}nih.gov
↵* Contributed equally.
Posted April 29, 2021.
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
